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Abstract
The CO2 laser was invented in 1963 by Kumar Patel. Since the early 1970s, CO2 laser has proved to be an effective
method of treatment for patients with several types of oral lesions, including early squamous cell carcinoma.
Laser surgery of oral premalignant disorders is an effective tool in a complete management strategy which includes
careful clinical follow-up, patient education to eliminate risk factors, reporting and biopsying of suspicious lesions and
any other significant lesions. However, in a number of patients, recurrence and progression to malignancy remains a risk.
CO2 laser resection has become the preferred treatment for small oral and oropharyngeal carcinomas. Laser resection
does not require reconstructive surgery. There is minimal scarring and thus, optimum functional results can be expected.
New and improved applications of laser surgery in the treatment of oral and maxillofacial/head and neck disorders are
being explored. As more surgeons become experienced in the use of lasers and as our knowledge of the capabilities
and advantages of this tool expands, lasers may play a significant role in the management of different pathologies.
Introduction
Since the 1970's lasers have been increasingly used in oral
and maxillofacial/head and neck surgery. Their effect on
tissue is determined by their wavelength and the tissue
specific absorption. Lasers can be used for evaporation,
excision and coagulation of tissue. The commonly used
lasers include carbon dioxide (CO2), neodymium:yttrium-
aluminium-garnet (Nd:YAG) and Argon lasers. Also, light
and laser light are used for the diagnosis of mucosal
lesions. For example, by using different excitation wave-
length autofluorescence, abnormal lesions can be detected
and analysed [1].
Literature in oral and maxillofacial/head and neck on-
cology continues to support the use of lasers in surgery
of premalignant and malignant lesions. Several author-
ities have explored the indications, techniques, results,
benefits and risk issues of lasers used in this field. CO2
laser is primarily suited for transoral resections of pre-
malignant and early oral carcinomas. The 5-year survival
rates and the postoperative oral function with the carbon
dioxide laser are comparable with those obtained following
conventional surgical methods. The Nd:YAG laser, because
of its unique characteristics (its ability to coagulate and
ablate; it is not as precise a cutting tool as the CO2
laser), has specific advantage in the treatment of large
oral vascular malformations [2].
The CO2 laser was one of the earliest gas lasers invented
by Kumar Patel of Bell Labs [3] in 1964, and it still remains
the most useful lasers in oral and maxillofacial/head and
neck surgery practice. CO2 lasers are by far the highest-
power continuous wave lasers that are currently available.
They are also very useful in oral surgical procedures since
the energy is maximally absorbed by water in the oral tis-
sues [1,2]. Laser therapy has been a preferred treatment
option for oral leukoplakia since the mid 1980s.
Morphological and functional recovery following laser
surgery is superior when compared with conventional cold
instrumentation surgery and electrocautery [1,2]. Compared
to conventional surgery, epithelial regeneration and wound
re-epithelialisation are delayed [1,2] but without any det-
rimental effect on outcome. Tuncer et al. [4] compared
conventional surgery to laser surgery on oral soft tissue
pathology. They evaluated the effect of collateral ther-
mal damage on histopathological diagnosis, pain control
and postoperative complications. Histological examin-
ation of the specimens showed that collateral thermal
damage on the incision line did not have adverse effect
on the histopathological diagnosis. Pain control was
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tions were seen in both groups.
Ishi et al. [5] compared the results of partial glossect-
omy in rabbits: in group one, the excised edges of the
wound were left unsutured after partial glossectomy with
the CO2 laser excision, in group two, the wound was
closed after CO2 laser surgery. While in group three, the
control group, the wound was closed after partial glos-
sectomy with electrocautery. The results were assessed
at two, four and eight weeks postoperatively. There was
a significant difference in the tongue width between
groups 1 and 3 at each time point. There was also a sig-
nificant difference in the tongue width between groups 2
and 3 at 8 weeks postoperatively. Histologically, the scar
tissue of the wound was extensive in the control group,
whereas it was localized in the laser group. They con-
cluded that postoperative dysfunction was reduced when
excised edges were left unsutured after partial glossect-
omy with the CO2 laser.
Advantages of laser management of oral pathology
The use of lasers in the management of oral disorders
has been implemented for several years. The advantages
of this approach include minimal damage to adjacent
tissue, delayed acute inflammatory reaction and reduced
myofibroblast activity, leading to reduced wound con-
traction and scarring. Reduction of collagen in the post-
operative phase maintains soft tissue movement. The
laser-treated area can be left exposed to granulate, thus
obviating any need for skin grafting or wound dressing
[1,2].
Since dissection usually follows the approach of ‘en block’
removal of tumour tissue, rather than anatomically based
dissection, more normal oral tissues can be preserved. This
results in greater preservation of oral function such as
swallowing and speech...etc. [1,2,6].
When laser is used, the operating time is reduced.
Patients require a shorter hospital stay. The laser proced-
ure is thus cost-effective. Should there be a recurrence or
malignant transformation, laser can be used again. Laser
usage also does not impose any limitations to implement-
ing multi-modal management with conventional surgery,
chemo-radiation and/or photodynamic therapy [1-3,6].
Bornstein et al. [6] assessed 139 patients with 164
intraoral pathological lesions treated with laser. Intra-
operative pain control was achieved with topical anaes-
thesia alone in almost a third of cases. In the remaining
111 lesions, a local anaesthetic was necessary. For pain
relief after the operation, 101 patients (72.7 %) used an ad-
hesive wound paste, without any additional oral analgesic.
The thermal damage from the laser on the borders of the
biopsy specimens did not interfere with the pathologist's
establishment of a firm diagnosis. This suggests that laser
surgery is an appropriate instrument for excisional biop-
sies of oral soft tissue lesions.
Oral premalignant disorders
Hamadah and Thomson [7] assessed the outcome of 78
patients undergoing CO2 laser excision of newly diag-
nosed single oral dysplasias and the influence of clinico-
pathological parameters, socio-demographic factors and
the presence or absence of residual dysplasia in excision
margins. Their results showed that there was no statisti-
cally significant association between patients' age, gender,
lesion appearance, site of origin, histopathological grad-
ing, presence of dysplasia in resection margins, or alco-
hol consumption and clinical outcome. Smokers, however,
were at significantly higher risk of dysplasia recurrence
compared to ex-smokers or non-smokers.
Chandu and Smith [8] assessed forty-three patients
with73 primary oral leukoplakia for outcome and factors
affecting survival. It was postulated that alcohol con-
sumption and previous malignancy are significant prog-
nostic indicators. Continuation to smoking as a risk
factor approached significance. Results from this study
were comparable to other studies using other conven-
tional modalities.
van der Hem et al. [9] reported on the outcome of a
group of 200 patients with 282 oral leukoplakias who
were treated by CO2 laser evaporation. In the follow-up
period (52 months), 251 treated leukoplakias (89.0 %)
did not show a recurrence and 28 (9.9 %) local recur-
rences were observed. In three patients (1.1 %), trans-
formation to squamous cell carcinomas were identified.
Although the benefits of CO2 laser surgery in the man-
agement oral dysplasias have been evaluated, little con-
sideration has been given to the factors which may
influence treatment outcome, especially amongst patients
developing recurrence or malignant transformation.
Schoelch et al. [10] assessed seventy consecutive laser-
treated patients with oral leukoplakia. Thirty-nine patients
had some degree of microscopic dysplasia. Six demon-
strated high-risk proliferative verrucous leukoplakia. Lasers
employed were the CO2 and Nd:YAG lasers. The authors
reported complete control in 29 patients. 19 patients had
small recurrences which were removed with further laser
surgery which resulted in control of their disease. 2
patients had total recurrences; and 5 patients developed
full-fledged squamous cell carcinoma at the lesion site.
Verrucous lesions had an especially high rate of recurrence
(83 %), with 9 of 12 ultimately controlled with subsequent
surgeries. They concluded that laser is an effective tool for
surgery of oral leukoplakia. It plays an important role as a
part of an overall management strategy which includes
careful clinical follow-up, patient education to eliminate
risk factors, report suspicious lesions, and biopsy these
and any other significant lesions as appropriate. However,
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remains a risk.
Chiesa et al. [11] retrospectively analysed 167 consecu-
tive patients with oral leukoplakias operated on by CO2
laser resection. Within 5 years there were 69 patients
with at least one unfavourable event. This included: 31
local relapses, 27 new leukoplakias, 5 oral carcinomas
and 6 other neoplasms elsewhere. The Cox regression
analysis showed that age of operated patients and size of
resected lesions are significantly predictive for develop-
ment of relapses, new leukoplakias and carcinoma.
Oral cancer
Surgery continues to be the well established mode of initial
definitive treatment for the majority of oral squamous cell
carcinoma (OSCC) patients [12]. The aim of surgical abla-
tion for OSCC is the removal of all viable tumour tissue.
This intuitively is associated with better overall prognosis.
Resection of the primary tumour is employed with dissec-
tion and removal of the cervical lymphatic chain, when
indicated. Reconstruction of the defect can be by loco-
regional repair or by distant free tissue transfer. Radio-
therapy plays a key role in the management of early-
stage and locally advanced OSCC, either alone or more
frequently, combined with surgery and/or chemotherapy
[13].
Thirty-seven consecutive patients with cancer of the
anterior two-thirds of the tongue without clinical neck
lymph nodes or distant metastasis were treated with
transoral CO2 laser microsurgery. Wang et al. [14] resected
the tumour under surgical microscope. Of the 28 patients
in the T1/T2 group, 26 patients did not receive postopera-
tive radiotherapy. The local control rate in all 37 patients
at 5 years was 93.6 %. No local recurrence occurred in the
T1 or T2 cases. Nine patients suffered from neck recur-
rence and the neck control rate at 5 years was 74.6 %. Eight
of these nine patients were salvaged by surgery with adju-
vant radiotherapy, and six of them finally achieved disease-
free status. The 5-year disease-free survival rate was 88 %.
Ishii et al. [15] compared the rate of recurrence and
subsequent metastasis between a group of patients trea-
ted with laser surgery and a group treated with radio-
therapy (interstitial implant). Laser monotherapy with
CO2 laser was carried out on 18 cases for squamous cell
carcinoma of the mobile tongue. The cure rate of pri-
mary tumors was 83.3 %. One patient had subsequent
metastasis after laser surgery. No differences were found
in the rate of recurrence between the two groups.
Werner et al. [16] reviewed the published data on onco-
logic laser surgery for the treatment of head and neck car-
cinomas, along with their own clinical experience with
transoral laser surgery for the treatment of carcinomas of
the oral cavity, pharynx, and larynx. They concluded that
laser surgery has achieved a key position in minimally
invasive treatment concepts in the ears, nose, and throat
area, and especially for the treatment of malignancies of
the upper aerodigestive tract.
Thomson and Wylie [17] reviewed the records of 57
consecutive laser-treated patients presenting over a 4-year
period with histologically confirmed dysplastic lesions.
Leukoplakias were the commonest clinical lesions (69 %),
whilst the floor of the mouth was the most frequent ana-
tomical site (42 %). Laser surgery successfully excised 55
precancerous lesions, 11 of which exhibited more severe
dysplasia or neoplasia compared with initial biopsy. Of
these patients, 76 % remained disease-free, whilst 24 %
developed new dysplastic lesions at distinct or multiple
sites, often exhibiting increased dysplasia. Of the patients
experiencing recurrence, 7 % developed OSCC, whilst a
further 3.5 % presented with other aerodigestive tract
cancers.
Recent studies in our unit
In a prospective study carried out at the UCLH Head and
Neck Centre [18], a total of 123 oral premalignant disor-
ders from 77 consecutive patients were treated with CO2
laser (resection and/or ablation) (Figure 1). The average
age was 58±4.8 years. The recovery of all patients was un-
eventful. Comparisons with the clinical and histopatho-
logical features and rate of recurrence as well as malignant
transformation were made. The patients were followed-up
for a mean of 6.4 years, and biopsies taken where changes
suggestive of malignant development were noted.
Homogenous leukoplakias were identified in 31 patients,
34 patients had non-homogenous leukoplakias and 12
patients had erythroplakias. Ex- and lifelong smokers
formed 88.3 % of the recruited patients. Current smokers
and drinkers formed 55.8 % of the cohort. Erythroplakias
were solely identified in heavy lifelong smokers. The most
common primary anatomical locations were the lateral
border of tongue, floor of mouth and buccal mucosa.
Moderate dysplasia was identified in 42 patients while 18
patients showed severe dysplasia.
Laser resection was employed in selected cases (68
patients) and the margins were clear in 53 and showed
mild-moderate dysplasia in the involved margins; the rest
of the patients had laser ablation. The rate of recurrence
had no significant association with the location but the
severity of epithelial dysplasia. The rate of first recur-
rence after laser surgery was 19.5 %. Malignant trans-
formation was observed in 8 patients (10.4 %), in the
tongue and the floor of mouth. Recurrence and malig-
nant transformation was mainly identified in erythropla-
kias and non-homogenous leukoplakias.
Another prospective study [19] was carried out at the
same centre to determine the oncological outcomes fol-
lowing transoral CO2 laser resection of T1/T2 N0 OSCC
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free survival were evaluated. The data included a range of
clinical, operative and histopathological variables related to
the status of the surgical margins. Data collection also
included recurrence, cause of death, date of death and last
clinic review.
Ninety patients (64 males and 26 females) participated
in this study. Their mean age at the 1
st diagnosis of
OSCC was 63.5 years. Two-thirds of the patients were
Caucasians. Usually patients presented with ulcers of the
tongue, floor of mouth or buccal mucosa. Current and
ex-smokers represented 82.2 % of the cohort; while current
and ex-drinkers were 78.9 %. Co-morbidities included
history of oral lichen planus, oral submucous fibrosis,
immunodeficiency, oral dysplasia and/or OSCC. Clinically
81 patients had T1N0 disease while 9 had T2N0 disease.
Pathological analysis revealed that nearly half of the
patients had moderately differentiated OSCC, 18 had mod-
erately to poorly differentiated and 19 poorly differentiated
carcinoma. Study of the tumour margins showed that the
mean depth of invasion was 5.7 mm. Primary tumour clear-
ance was achieved in 73 patients. Recurrence was identified
in 11 (12 %) patients. The mean age of 1
st diagnosis of the
recurrence group was 76.4 years. Most common clinical
presentation in the recurrence group was an ulcer involving
the tongue or buccal mucosa; most commonly identified in
current or ex-smokers or drinkers. Recurrence was identi-
fied in patients whom clinical and radiological staging
revealed involvement of the locoregional lymphnodes. The
surgical margins in this group were also evaluated following
re-laser excision or surgical excision±neck dissection. Fol-
l o w - u ps h o w e da3 - y e a rs u r v i v a lo f8 6 . 7% .O ft h et w e l v e
patients who died, nine died from non-cancer related
causes, two from locoregional spread and one from pul-
monary metastasis.
Discussion
Literature in oral and maxillofacial/head and neck on-
cology continues to support the use of lasers for surgi-
cal removal of malignant lesions of the oral cavity. The
5-year survival rates, and the postoperative function
with the laser are at least comparable with those obtained
using other surgical methods [2]. The advantages of laser
therapy include minimal postoperative pain, conservative
Figure 1 CO2 laser excision of oral premalignant disorder. A: patient presented with non-homogenous leukoplakia of the posterior buccal
area and the retromolar trigone; B: CO2 laser excision of the lesion carried out under general anaesthesia; C: 3 margins (superior, anterior and
posterior) have been excised and released prior to release of the inferior margin; D: complete lesion excision and subsequent laser of the base to
achieve haemostasis; E: 1 week post excision showing good heeling with minimal frictional keratosis; F: 1 month post excision showing normal
oral mucosal with regression of keratosis. Adapted with permission from: Jerjes W, Upile T, Hamdoon Z, Al-Khawalde M, Morcos M, Mosse CA, Hopper
C. CO2 laser of oral dysplasia: clinicopathological features of recurrence and malignant transformation. Lasers Med Sci. 2012 Jan;27(1):169–79.
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of need for sutures. Laser excision is well tolerated by
patients with no intraoperative or postoperative adverse
effects. Patients heal with no postoperative loss of func-
tion. CO2 laser offers equitable surgical option when per-
forming excision of intraoral lesions [20].
Surgical removal of oral premalignant disorders seems
one realistic option. Many professionals use scalpel, laser,
or cryoprobe as a surgical tool of their choice. The intention
of care is to detect, treat and prevent malignant transform-
ation. Several management protocols have been recom-
mended. However, no large trials have shown an ultimate
and reliable intervention. No high evidence-based study
exists on which to reliably recommend a treatment option.
In our opinion, laser excision offers preferred option to
electrofulguration for reasons stated above. It has been
argued that such operative interventions aggravate dysplasia
and that surgical removal of aneuploidic lesions does not
improve mortality rates. CO2 laser resection has become
the elective treatment for small oral and oropharyngeal car-
cinomas [21].
A further improvement of outcome might be expected
by the combination of adjuvant radiotherapy. Pradier et al.
[22] reported a study which included 208 patients with
advanced squamous cell carcinoma of the head and neck
following CO2 laser resection, patients were given post-
operative radiotherapy. Primary sites included oral cavity,
oropharynx, larynx and hypopharynx. In this series,
transoral laser surgery in combination with adjuvant
radiotherapy in patients with advanced head-and-neck
tumours resulted in locoregional control and disease
specific survival rates similar to those reported for rad-
ical surgery followed by radiotherapy.
The bystander collateral thermal damage of the margin
may pose some difficulty in pathological interpretation of
laser margins. Photo-coagulation of proteins may mask or
alter surface epitopes, rendering some immunohistochem-
ical stain less useful. Obviously a highly experienced sub-
speciality head & neck pathologist is an essential member
of the team. There is also an uncompromising need for
good communication between the operating room and the
pathology department. This can range from annotated
photo-documentation and narrated video to having phys-
ical presence of the pathologist in the theatre room [1,2].
Inadvertent laser damage to the patient or operating the-
atre staff is an acknowledged risk. However, no data exists
to verify the safety margin of commonly employed precau-
tions. A study by Ahmed et al. [23] assessed the safety
margins of protective strategies commonly adopted when
using lasers to resect tumours of the head and neck. Gauze
swabs, neurosurgical patties, surgical gloves, paper drapes
and conventional PVC endotracheal (ET) tubes were tested
against the following laser variables: power, beam charac-
teristics and angle of beam incidence (90 & 45 degrees).
Figure 2 CO2 laser excision of oral cancer. Top left: patient presented with a multinodular lesion of the ventrolateral tongue. Incisional biopsy
confirmed squamous cell carcinoma. Staging of the patient revealed that there was no nodal involvement or distant metastasis. The patient
elected to have the tumor excised with CO2 laser under general anesthesia. Top right: the nodules are identified and marked with an ink before
excision. Bottom left: intraoperative CO2 laser excision of the tumor. Bottom right: complete tumor excision and laser of the base to achieve
hemostasis. Adapted with permission from: Jerjes W, Upile T, Hamdoon Z, Mosse CA, Akram S, Hopper C. Prospective evaluation of outcome after
transoral CO(2) laser resection of T1/T2 oral squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Aug;112(2):180–7.
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recorded in seconds (s). The materials were tested dry and
some, where appropriate, were tested wet. The results
demonstrated dry gauze swabs, neurosurgical patties and
paper drapes provided 0 second protection at 2 W (lowest
power). However, when wet, the laser failed to penetrate
the swabs and neurosurgical patties, even after 180 s of con-
tinuous application. Gloves (single or double layer), and ET
PVC cuffs were penetrated in less than 1 s at 2 W. Time to
penetrate a size 6.0 PVC ET tube at 2 W continuous setting
increased from<1 s at 90 degrees to 42 s at 45 degrees.
In addition to the various oral lesions, the management
of patients with sleep apnoea, temporomandibular joint
derangements, dental implants and posttraumatic facial
scarring has improved significantly with the advent of
laser surgery. As further laser systems develop and their
technology become more advanced, a thorough under-
standing of the principles of their use is paramount to
ensure safe and effective patient care [24].
Conclusion
Over the past few decades, the use of lasers among oral
and maxillofacial/head and neck surgeons has grown dra-
matically. Their evolution within the specialty not only has
broadened current surgical options for treatment, but also
contributed to a variety of new procedures that are now a
commonplace in oral and maxillofacial/head and neck
surgery.
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